Skip to Main content
New interface


Social networks

Researcher identifiers

Number of documents


Sophie Leducq - Doctorante en Méthodologie et Biostatistiques

Journal articles18 documents

  • Sarah Ventejou, Thibaud Genet, Sophie Leducq, Lisa Baldinger, Philippe Lanotte, et al.. Multiple erythema migrans and carditis-related atrial fibrillation: exceptional manifestations of early disseminated Lyme disease. European Journal of Dermatology, John Libbey Eurotext, 2021, 31 (1), pp.112-114. ⟨10.1684/ejd.2021.3976⟩. ⟨hal-03185968⟩
  • Sybille Giraud, Sophie Leducq, Thibault Kervarrec, Sébastien Barbarot, Othman Laghmari, et al.. Spectrum of imiquimod-induced lupus-like reactions: Report of two cases.. Dermatologic Therapy, Wiley, 2020, 33 (1), 4 p. ⟨10.1111/dth.13148⟩. ⟨hal-02622833⟩
  • Mahtab Samimi, A. Le Gouge, F. Boralevi, T. Passeron, F. Pascal, et al.. Topical rapamycin versus betamethasone dipropionate ointment for treating oral erosive lichen planus: a randomized, double‐blind, controlled study. Journal of the European Academy of Dermatology and Venereology, Wiley, 2020, 34 (10), pp.2384-2391. ⟨10.1111/jdv.16324⟩. ⟨hal-02972478⟩
  • Sophie Leducq, Mahtab Samimi, Claire Bernier, Angele Soria, Emmanuelle Amsler, et al.. Efficacy and safety of methotrexate versus placebo as add-on therapy to H1 antihistamines for patients with difficult-to-treat chronic spontaneous urticaria: A randomized, controlled trial. Journal of The American Academy of Dermatology, Elsevier, 2020, 82 (1), pp.240-243. ⟨10.1016/j.jaad.2019.07.097⟩. ⟨hal-02623128⟩
  • S. Leducq, S. Duchatelet, J. Zaragoza, S. Ventéjou, A. de Muret, et al.. A previously unreported frameshift ATP 2C1 mutation in a generalized Hailey–Hailey disease. Journal of the European Academy of Dermatology and Venereology, Wiley, 2020, 34 (3), pp.e118-e120. ⟨10.1111/jdv.16038⟩. ⟨hal-03185897⟩
  • Sophie Leducq, Agnès Caille, Laurence Le Cleach, Mahtab Samimi, Elsa Tavernier, et al.. Research Techniques Made Simple: Randomized~Controlled Trials for Topical Drugs in~Dermatology: When~and How Should We Use a~Within-Person Design?. Journal of Investigative Dermatology, Nature Publishing Group, 2020, 140 (5), pp.931-938.e1. ⟨10.1016/j.jid.2020.03.945⟩. ⟨hal-03159474⟩
  • C Prouteau, M Dinulescu, E Oger, C Pruvost-Balland, S Buche, et al.. Concordance of severity scores assessed on photographs in Hidradenitis suppurativa. British Journal of Dermatology, Wiley, 2020, 182 (2), pp.515-516. ⟨10.1111/bjd.18480⟩. ⟨hal-02308311⟩
  • C El Habnouni, Sophie Leducq, M Garnier, Guillaume Desoubeaux, Mahtab Samimi. Image Gallery: Tungiasis in four steps. British Journal of Dermatology, Wiley, 2019, 180 (4), pp.e106. ⟨10.1111/bjd.17459⟩. ⟨hal-02443973⟩
  • Muriel Ouedraogo, Sarah Ventejou, Sophie Leducq, Guillaume Desoubeaux, Annabel Maruani. Crusts on the Eyelashes. J Pediatr, 2019, ⟨10.1016/j.jpeds.2019.02.002⟩. ⟨hal-02443905⟩
  • Romain Gabeff, Roba Safar, Sophie Leducq, Annabel Maruani, Guillaume Sarrabay, et al.. Successful therapy with secukinumab in a patient with generalized pustular psoriasis carrying homozygous IL36RN p.His32Arg mutation. International Journal of Dermatology, Wiley-Blackwell, 2019, 58 (1), pp.e16-e17. ⟨10.1111/ijd.14293⟩. ⟨hal-02566764⟩
  • Alexandre Gueutier, Sophie Leducq, Aline Joly, Laurence Picon, Loic Vaillant, et al.. Efficacy of vedolizumab in granulomatous cheilitis refractory to TNFα inhibitors. International Journal of Dermatology, Wiley-Blackwell, 2019, 58 (12), pp.e236-e237. ⟨10.1111/ijd.14638⟩. ⟨hal-02623231⟩
  • Sophie Leducq, Sandy Vrignaud, Gérard Lorette, Denis Herbreteau, Vincent Dubée, et al.. Topical rapamycin (sirolimus) for treatment of cutaneous microcystic lymphatic malformation of the gluteal area. European Journal of Dermatology, John Libbey Eurotext, 2019, 29 (1), pp.82-83. ⟨10.1684/ejd.2018.3440⟩. ⟨hal-02619966⟩
  • Sophie Leducq, Agnès Caille, Sébastien Barbarot, Nathalie Beneton, Didier Bessis, et al.. Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial.. Trials, BioMed Central, 2019, 20 (1), ⟨10.1186/s13063-019-3767-8⟩. ⟨hal-02622848⟩
  • X. Grimaux, S. Leducq, P. Goupille, A. Aubourg, E. Miquelestorena-Standley, et al.. Ulcérations buccales aphtoïdes inaugurales d’une maladie inflammatoire chronique de l’intestin induite par le sécukinumab. Annales de Dermatologie et de Vénéréologie, Elsevier Masson, 2018, 145 (11), pp.676-682. ⟨10.1016/j.annder.2018.07.009⟩. ⟨hal-02621008⟩
  • M. Samimi, M. Durieux-Verde, A. Caille, J. Mazereeuw-Hautier, O. Boccara, et al.. Clinical and haemodynamic risk factors associated with discrepancies in lower limb length with capillary malformations: data from the national paediatric French cohort CONAPE. British Journal of Dermatology, Wiley, 2018, 178 (2), pp.520 - 526. ⟨10.1111/bjd.16017⟩. ⟨hal-01737962⟩
  • Marie Chinazzo, Guillaume Desoubeaux, Sophie Leducq, Didier Bessis, Catherine Droitcourt, et al.. Prevalence of Nail Scabies: A French Prospective Multicenter Study. The Journal of Pediatrics, Elsevier, 2018, 197, pp.154-157. ⟨10.1016/j.jpeds.2018.01.038⟩. ⟨hal-01974312⟩
  • Annabel Maruani, Marine Durieux-Verde, Juliette Mazereeuw-Hautier, Olivia Boccara, Ludovic Martin, et al.. Search for RASA1 Variants in Capillary Malformations of the Legs in 113 Children: Results from the French National Paediatric Cohort CONAPE. Acta Dermato-Venereologica, Society for Publication of Acta Dermato-Venereologica, 2018, 98 (2), pp.251-255. ⟨10.2340/00015555-2835⟩. ⟨hal-02621329⟩
  • Annabel Maruani, Olivia Boccara, Didier Bessis, Laurent Guibaud, Pierre Vabres, et al.. Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design. Trials, BioMed Central, 2018, 19 (1), pp.340. ⟨10.1186/s13063-018-2725-1⟩. ⟨hal-01913363⟩

Conference papers1 document

  • Sophie Leducq, Mahtab Samimi, Claire Bernier, Angele Soria, Emmanuelle Amsler, et al.. Evaluation of a low-dose methotrexate added to h1-antihistamines regimen for severe chronic spontaneous urticaria: a phase III, randomized, placebo-controlled trial. 24. World Congress of dermatology (WCD 2019), Jun 2019, Milan, Italy. ⟨hal-02736447⟩